Pathological gambling in PD
Did the devil make me do it?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Since the early descriptions of gambling behavior in patients with Parkinson disease (PD),1,–,3 it has become well-established that pathologic gambling is one of a spectrum of impulse control disorders (ICDs) to which they are prone. Other such behaviors include compulsive sexual behavior, buying, and eating. A cross-sectional study of over 3,000 patients with PD found that the odds of having an ICD were 2- to 3-fold higher in those taking dopamine agonists (DA), though levodopa itself was also associated with ICDs to a lesser extent.4 It is also clear from a number of studies that withdrawal of the offending DA typically results in marked improvement in the ICD.5 As a result of these observations, it is now routine practice for physicians to counsel patients with PD about the risk of ICDs when prescribing DAs, with a particular emphasis on prompt notification of the treating physician when these problems develop.
As striking and disabling as these behaviors can be, it is also remarkable how uncommon pathological gambling is (5%) in patients with PD taking levodopa, DAs, and other medications.4 If …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Clinical and Ethical Challenges
Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson diseaseHoward D. Weiss, Laura Marsh et al.Neurology: Clinical Practice, December 10, 2012 -
Article
Longitudinal analysis of impulse control disorders in Parkinson diseaseJean-Christophe Corvol, Fanny Artaud, Florence Cormier-Dequaire et al.Neurology, June 20, 2018 -
Brief Communications
Clinical features associated with impulse control disorders in Parkinson diseaseGregory Pontone, James R. Williams, Susan Spear Bassett et al.Neurology, October 09, 2006 -
Article
Impaired corticostriatal connectivity in impulse control disorders in Parkinson diseaseNicolas Carriere, Renaud Lopes, Luc Defebvre et al.Neurology, April 29, 2015